Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin in Children With STEC-HUS
NCT03776851Phase 4Completed
- Sponsor
- Hospital General de Niños Pedro de Elizalde
- Start
- Jan 2019
- Primary completion
- Dec 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in anemia comparing Erythropoietin with Standard of Care (2 arms). Primary endpoint: Number of Red Blood Cell Transfusions at 36 months. Started Jan 2019; status: completed.
02
Drugs
erythropoietin
03
Conditions
anemia
Beyond the preview
Go deeper on NCT03776851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03776851.